Cargando…
P349: CRISPR/CAS9 SCREEN IDENTIFIES PTPMT1 AS AN ESSENTIAL GENE FOR ACUTE LYMPHOBLASTIC LEUKEMIA PROLIFERATION
Autores principales: | LI, Jiazheng, Lu, Lihua, Luo, Luting, Wang, Lingyan, Hu, Jianda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428461/ http://dx.doi.org/10.1097/01.HS9.0000968308.87712.e4 |
Ejemplares similares
-
Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia
por: Jiang, Chuang, et al.
Publicado: (2022) -
Identification of Early Recurrence Factors in Childhood and Adolescent B-Cell Acute Lymphoblastic Leukemia Based on Integrated Bioinformatics Analysis
por: Huang, Yan, et al.
Publicado: (2020) -
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
por: Bahrami, Ehsan, et al.
Publicado: (2023) -
PB1804: SLC7A11 IS A POTENTIAL THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA
por: LI, Jiazheng, et al.
Publicado: (2023) -
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia
por: Schneider, Pauline, et al.
Publicado: (2023)